Dybbs Michael 4
4 · SUTRO BIOPHARMA, INC. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Dybbs Michael
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-08+25,000→ 25,000 totalExercise: $5.12Exp: 2033-06-08→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 8.33% of the total shares monthly, commencing July 8, 2023, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2024 annual stockholders meeting or June 8, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.